Negative controls aid precision of immune response monitoring. For HLA-A*02:01 alleles, MBLI offers a “Negative Tetramer” in BV421, PE or APC.
Ensure Accurate Immune Monitoring Results with Negative Controls
In Vivo Transfection Experiment Reagents
OZ Biosciences offers solutions to improve your In Vivo Transfections or Infections.
Deliver Functional Proteins and Antibodies into Living Cells
OZ Biosciences offers solutions to deliver functional Proteins and Antibodies into living cells.
Visualising Protein-Protein Interaction with FLUOPPI Technology
MBLI’s innovative technology, Fluoppi, simplifies the visualisation of protein-protein interaction.
Validation of Neoantigen In Silico Prediction using QuickSwitch™ Kits
Research findings indicate that neoantigens have the potential to activate tumour-specific T-cell-mediated anti-tumour immune responses.
Chimeric Antigen Receptor (CAR) T Cell Therapy
Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary approach in the field of cancer immunotherapy.
Immune Checkpoints
ProSci offers reagents that can be used to study the actions of multiple immune checkpoint proteins such as CTLA-4, PD-1, & its ligands PD-L1 & PD-L2.
Viral Infectious Diseases
To support research & studies into infectious diseases, ProSci has reagents for the study of many viral disease agents inc. Covid, HIV, & Influenza.
How AllCells’ Expanded Donor Collection Facilities Help You to Recruit the Right Donors and Scale Your Cell and Gene Therapy Development
AllCells’ has thousands of well-characterised, highly engaged recallable donors, with specific attributes, at collection sites across the US & Europe.
Overcoming the Donor Selection Challenges to Drive Success in Cell and Gene Therapy Development and Commercialisation
AllCells’ Pre-Characterised Donor Selection Program expedites screening, selecting & collecting from donors for downstream clinical manufacturing.